CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leader in Advanced Organ (AOP) technology, is glad to announce that we are attending the Pediatric Partial Heart Transplants: An Innovative Approach to Decrease Waitlist Mortality and Organ Discards and support the event.
Donation and transplantation professionals are relentlessly exploring innovative ways to decrease waitlist mortality and increase organ utilization within the adult and pediatric population. Most recently, a team at Duke Health performed the first world’s first pediatric partial heart transplant that involved the fusing of donated arteries and valves to a patient’s existing heart. Not only does this remarkable procedure have the potential to extend the life expectancy of pediatric patients who otherwise would be waiting for a life-saving heart transplant, but it allows surgeons to make use of hearts that would otherwise be discarded. Join this event to hear from Dr. Joseph Turek, Duke’s Chief of Pediatric Cardiac Surgery, and his colleagues who assisted in making this surgery a success to learn more about the overall process from procurement to transplant.
For more information: Pediatric Partial Heart Transplants
About Paragonix Technologies
Paragonix Technologies creates organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix is a leading provider of FDA cleared and CE marked transport devices for organ preservation.
Follow us on Twitter: @ParagonixSherpa
Connect with us on LinkedIn: Paragonix Technologies
Like Us on Facebook: Paragonix SherpaPak
L-399 Rev 1
Contacts
Media Contact
Adam Lafreniere, Sr. Director, Marketing
marketing@paragonixtechnologies.com
FlightAware® is a registered trademark of FlightAware, a division of Collins Aerospace